Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

IARC activities in mycotoxin research

M Castegnaro1, C P Wild

  • 1Unit of Environmental Carcinogenesis, International Agency for Research on Cancer, Lyon, France.

Natural Toxins
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Eosinophilic myocarditis: diagnostic pitfalls and therapeutic challenges. A Case Series.

Frontiers in cardiovascular medicine·2026
Same author

International cancer seminars: a focus on esophageal squamous cell carcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

The exposome in practice: Design of the EXPOsOMICS project.

International journal of hygiene and environmental health·2016
Same author

Base changes in tumour DNA have the power to reveal the causes and evolution of cancer.

Oncogene·2016
Same author

Detection of DNA methylation adducts in Hodgkin's disease patients treated with procarbazine.

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals·2013
Same author

DNA base adducts in urine andwhite blood cells of cancer patients receiving combination chemotherapies which include N-methyl-N-nitrosourea.

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals·2013
Same journal

Reporter gene assays for algal-derived toxins.

Natural toxins·2000
Same journal

Alteration in sphingolipid metabolism: bioassays for fumonisin- and ISP-I-like activity in tissues, cells and other matrices.

Natural toxins·2000
Same journal

A yeast bioassay for trichothecenes.

Natural toxins·2000
Same journal

A receptor binding assay for paralytic shellfish poisoning toxins: recent advances and applications.

Natural toxins·2000
Same journal

Methodological improvement of the protein phosphatase inhibition assay for the detection of okadaic acid in mussels.

Natural toxins·2000
Same journal

Using an enzyme linked immunosorbent assay (ELISA) and a protein phosphatase inhibition assay (PPIA) for the detection of microcystins and nodularins.

Natural toxins·2000
See all related articles

The International Agency for Research on Cancer (IARC) has long studied mycotoxins and their link to liver cancer. Research includes lab work, epidemiology, and risk assessment for primary cancer prevention.

Area of Science:

  • Toxicology
  • Epidemiology
  • Cancer Research

Background:

  • Mycotoxins, particularly aflatoxins, were identified as potential carcinogens shortly before IARC's establishment.
  • IARC initiated research into mycotoxins and liver cancer in 1968, reflecting an early focus on cancer in developing nations.

Purpose of the Study:

  • To detail IARC's sustained research efforts on mycotoxins, encompassing laboratory studies, epidemiological investigations, and carcinogenicity evaluations.
  • To explore the integration of mycotoxin exposure biomarkers into epidemiological studies.
  • To discuss future research directions for primary cancer prevention related to mycotoxins.

Main Methods:

  • Laboratory research on mycotoxin mechanisms of action and destruction methods.
  • Epidemiological studies incorporating biomarkers for mycotoxin exposure (e.g., aflatoxin, ochratoxin A).

Related Experiment Videos

  • Carcinogenic potency evaluation within the IARC Monographs series.

    • Main Results:

    • Development of mycotoxin exposure biomarkers integrated into epidemiological studies.
    • Comprehensive evaluation of carcinogenic risks of mycotoxins.
    • Sustained research focus driven by IARC's interest in cancer in developing countries.

    Conclusions:

    • IARC's long-standing research on mycotoxins has provided critical insights into their carcinogenic potential.
    • Integration of biomarkers and laboratory findings enhances epidemiological study validity.
    • Future research aims to leverage current knowledge for primary cancer prevention strategies.